Thu17Jun2021

Grand-Pa Products are not Allowed In Botswana

The Botswana Medicines Regulatory Authority (BoMRA) wishes to inform the public, healthcare practitioners, importers, and distributors that ALL Grand-Pa pain relief products (powder and tablets ) remain suspended from registration and therefore are not allowed in Botswana.

The suspension follows a decision by the Market Authorization Holder GlaxoSmithKline CH South Africa to temporarily halt the supply of these products to Botswana and other markets.

 

Download Now

File name: Grand-Pa Products are not Allowed In Botswana

3893 179